| Name | Title | Contact Details |
|---|
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
Prince William Health System is a Manassas, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Argentum is the leading national trade association serving companies that own, operate, and support professionally managed senior living communities in the United States.
TeamHealth Medical Call Center is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EHC Communicationsm Inc is a Dobbs Ferry, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.